Therapy management with sunitinib in patients with metastatic renal cell carcinoma: Key concepts and the impact of clinical biomarkers-Reference-Cited by-同舟云学术

Therapy management with sunitinib in patients with metastatic renal cell carcinoma: Key concepts and the impact of clinical biomarkers

Published:2013-05 Issue:3 Volume:39 Page:230-240
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Castellano Daniel,Ravaud Alain,Schmidinger Manuela,De Velasco Guillermo,Vazquez Federico

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference66 articles.

1. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

2. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy;Rabinovitch;J Clin Oncol,1994

3. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al., editors SEER cancer statistics review, 1975–2005. National Cancer Institute. ; 2008.

4. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

5. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry;Future Oncology;2020-12

2. Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors;World Journal of Gastroenterology;2018-12-14

3. Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma;Cancer Medicine;2016-10-19

4. Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine;Spine;2016-10-15

5. Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials;Clinical Genitourinary Cancer;2016-10